Inventor · disambiguated record
Ganfeng Cao
Also filed as: CAO GANFENG
32 granted patents·9 pending applications·347 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
41 records- 0198US9221845B2Processes and intermediates for making a JAK inhibitorINCYTE CORP·Filed 2015·Granted Dec 29, 2015·55 cites·30 claims
- 0298US8987443B2Processes and intermediates for making a JAK inhibitorINCYTE CORP·Filed 2014·Granted Mar 24, 2015·79 cites·17 claims
- 0397US11591318B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Feb 28, 2023·6 cites·19 claims
- 0497US11001571B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted May 11, 2021·15 cites·16 claims
- 0597US9487521B2Processes and intermediates for making a JAK inhibitorZHOU JIACHENG·Filed 2012·Granted Nov 8, 2016·74 cites·16 claims
- 0695US11905275B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2023·Granted Feb 20, 2024·2 cites·29 claims
- 0794US10723700B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2019·Granted Jul 28, 2020·7 cites·54 claims
- 0894US9862705B2Salts of a pim kinase inhibitorINCYTE CORP·Filed 2016·Granted Jan 9, 2018·13 cites·12 claims
- 0993US10329255B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2016·Granted Jun 25, 2019·15 cites·57 claims
- 1092US9714233B2Processes and intermediates for making a JAK inhibitorINCYTE CORP·Filed 2015·Granted Jul 25, 2017·6 cites·21 claims
- 1191US7307086B23-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2005·Granted Dec 11, 2007·21 cites·24 claims
- 1290US7511050B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2007·Granted Mar 31, 2009·14 cites·110 claims
- 1387US12247020B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2024·Granted Mar 11, 2025·0 cites·20 claims
- 1487US11505540B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2021·Granted Nov 22, 2022·1 cites·26 claims
- 1587US7462624B2Purinone derivatives as HM74a agonistsINCYTE CORP·Filed 2007·Granted Dec 9, 2008·8 cites·81 claims
- 1684US7678798B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2005·Granted Mar 16, 2010·5 cites·35 claims
- 1784US2025019366A1Salts of a pim kinase inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 1882US7618970B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2005·Granted Nov 17, 2009·5 cites·29 claims
- 1982US7449467B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsPFIZER·Filed 2005·Granted Nov 11, 2008·5 cites·31 claims
- 2080US12043614B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2022·Granted Jul 23, 2024·0 cites·5 claims
- 2180US7902205B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Mar 8, 2011·3 cites·36 claims
- 2280US2025206726A1Bipyrazole derivatives as jak inhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 2379US8268826B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2009·Granted Sep 18, 2012·3 cites·17 claims
- 2476US8362003B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2011·Granted Jan 29, 2013·2 cites·8 claims
- 2576US2025367205A1Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2674US8039478B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Oct 18, 2011·1 cites·22 claims
- 2774US7863285B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Jan 4, 2011·1 cites·27 claims
- 2874US7834021B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2003·Granted Nov 16, 2010·4 cites·4 claims
- 2970US11498900B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2020·Granted Nov 15, 2022·0 cites·45 claims
- 3070US8703783B2Purinone derivatives as HM74A agonistsZHENG CHANGSHENG·Filed 2011·Granted Apr 22, 2014·2 cites·7 claims
- 3164US12414953B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Sep 16, 2025·0 cites·70 claims
- 3261US9067921B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2014·Granted Jun 30, 2015·0 cites·7 claims
- 3361US2014371216A1Purinone derivatives as hm74a agonistsINCYTE CORP·Filed 2014·Application pending·0 cites
- 3461US2025011298A1Crystalline forms of a cdk9 inhibitor and uses thereofPRELUDE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3560US8563582B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsXUE CHU-BIAO·Filed 2009·Granted Oct 22, 2013·0 cites·8 claims
- 3660US2025361258A1Processes for making prmt5 inhibitorsPRELUDE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3758US8470827B23-aminocyclopentanecarboxamides as modulators of chemokine receptorsXUE CHU-BIAO·Filed 2008·Granted Jun 25, 2013·0 cites·35 claims
- 3858US2022251088A1Processes for Making PRMT5 InhibitorsPRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3956US2025197418A1Polymorphic Compounds And Uses ThereofPRELUDE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4055US8729063B23-aminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2012·Granted May 20, 2014·0 cites·17 claims
- 4154US2023357275A1Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (mcl-1) proteinPRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ganfeng Cao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →